Cardlytics (CDLX) vs J and Friends (JF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
J and Friends (JF) has outperformed Cardlytics (CDLX) over the past year, losing 12.6% versus a loss of 90.8%. Over five years, JF leads with a -77.8% price change compared with -99.9% for CDLX. J and Friends is the larger company by market cap ($16.5 million vs $6.4 million), about 2.6 times the size, while Cardlytics is growing revenue faster (-16.2% vs -66.8%).
Cardlytics converts more of its revenue into profit, with a net margin of -44.4% versus -82.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDLX | JF |
|---|---|---|
| Share price | $1.05 | $0.9001 |
| Market cap | $6.41M | $16.51M |
| 1-day change | -5.41% | -0.51% |
| YTD return | -90.87% | -1.09% |
| 1-year return | -90.79% | -12.61% |
| 5-year return | -99.85% | -77.78% |
| EPS (TTM) | $-6.63 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $233.27M | $1.60M |
| Revenue growth (YoY) | -16.18% | -66.81% |
| Net income (latest FY) | $-103.49M | $-1.32M |
| Gross margin | — | 71.53% |
| Operating margin | -43.65% | -83.85% |
| Net margin | -44.36% | -82.85% |
| 52-week high | $15.55 | $1.24 |
| 52-week low | $0.9598 | $0.81 |
| Distance from 52-week high | -93.25% | -27.41% |
| Analyst consensus | none | — |
| Avg. price target upside | +471.43% | — |
| Average volume | 61.72K | 6.51K |
| Shares outstanding | 6.10M | 17.13M |
| Employees | 275 | 30 |
| Sector | Technology | Technology |
| Industry | Computer Software: Programming Data Processing | Computer Software: Programming Data Processing |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- J and Friends is about 2.6 times larger than Cardlytics by market value ($16.51M vs $6.41M).
- JF has outperformed CDLX by 78.2 percentage points over the past year.
- Cardlytics is more profitable, keeping -44.4 cents of every revenue dollar as net income versus -82.9 cents for J and Friends.
- Cardlytics grew revenue faster in its latest fiscal year (-16.18% vs -66.81%).
About Cardlytics
CDLX stock →Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom.
Technology · Computer Software: Programming Data Processing · 275 employees
About J and Friends
JF stock →J and Friends Holdings Limited, together with its subsidiaries, provides merchant digitalization and commerce-enablement SaaS solutions to small and medium enterprises in Australia. The company offers food and beverage (F&B) solutions that enable restaurants, cafés, and other hospitality merchants to digitize core front-of-house and back-of-house workflows, including order intake, menu management, kitchen coordination, and store-level reporting while supporting omni-channel operations across dine-in, takeaway, and online ordering.
Technology · Computer Software: Programming Data Processing · 30 employees
CDLX vs JF FAQ
Which is bigger, Cardlytics or J and Friends?
J and Friends (JF) is larger, with a market capitalization of $16.51M compared with $6.41M for Cardlytics (CDLX).
Which stock has performed better over the past year, CDLX or JF?
JF returned -12.61% over the past 12 months, compared with -90.79% for CDLX (price return, excluding dividends). Past performance does not predict future results.
Are Cardlytics and J and Friends in the same industry?
Yes. Both are classified in the Computer Software: Programming Data Processing industry within the Technology sector.